Siemens Healthineers launches diagnostics carve-out, with Olyrian transformation expected to be completed by mid-2028
The diagnostics business, which manufactures more than 16 billion tests annually, will enter its next phase under an independent brand. But amid weakness in the Chinese market and pressure to improve profitability, the new company must still navigate cost and operational restructuring.